1. Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
    Dongli Cai et al, 2020, Cellular & Molecular Immunology CrossRef
  2. B7-H3: A promising therapeutic target for autoimmune diseases
    Yuting Chen et al, 2020, Cellular Immunology CrossRef
  3. Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer
    Jinye Ding et al, 2023, International Journal of General Medicine CrossRef
  4. B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density
    Phyu P. Aung et al, 2019, Clinical Cancer Research CrossRef
  5. B7-H3 targeted antibody-based immunotherapy of malignant diseases
    Theodoros Michelakos et al, 2021, Expert Opinion on Biological Therapy CrossRef
  6. Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3
    Takahiro Nakagomi et al, 2018, Cancers CrossRef
  7. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma
    Jing Bian et al, 2024, Scientific Reports CrossRef
  8. Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
    Qianqian Zhang et al, 2021, OncoTargets and Therapy CrossRef
  9. Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
    Roberta Mazza et al, 2022, Archivum Immunologiae et Therapiae Experimentalis CrossRef
  10. Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3
    Nan Li et al, 2021, Pharmacology & Therapeutics CrossRef
  11. The role of B7-H3 in tumors and its potential in clinical application
    Ranran Feng et al, 2021, International Immunopharmacology CrossRef
  12. mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
    Heng-Jia Liu et al, 2023, Nature Communications CrossRef
  13. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
    Ioannis-Alexios Koumprentziotis et al, 2024, Vaccines CrossRef
  14. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer
    Sai Han et al, 2018, Experimental Cell Research CrossRef
  15. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis
    Hang Su et al, 2024, Taiwanese Journal of Obstetrics and Gynecology CrossRef
  16. B7-H3 and digestive system cancers
    Liyun Zhou et al, 2021, European Journal of Inflammation CrossRef
  17. Clinical Insights Into Novel Immune Checkpoint Inhibitors
    Jii Bum Lee et al, 2021, Frontiers in Pharmacology CrossRef
  18. GOLM1 as a Potential Therapeutic Target Modulates B7-H3 Secretion to Drive Ovarian Cancer Metastasis
    Junhua Guan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  19. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
    Binghao Zhao et al, 2022, Journal of Hematology & Oncology CrossRef
  20. The type 1 transmembrane glycoprotein B7‐H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells
    Jiahui Zuo et al, 2018, FEBS Letters CrossRef
  21. B7-H3 Expression in Breast Cancer and Brain Metastasis
    Vaibhavi Joshi et al, 2024, International Journal of Molecular Sciences CrossRef
  22. B7-H3 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target
    Xiao Tan et al, 2024, Chinese Medical Journal CrossRef
  23. High B7‐H3 expression is linked to increased risk of prostate cancer progression
    Sarah Bonk et al, 2020, Pathology International CrossRef
  24. Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML
    Anudishi Tyagi et al, 2022, Blood CrossRef
  25. The novel non‐immunological role and underlying mechanisms of B7‐H3 in tumorigenesis
    Xiangqi Zhou et al, 2019, Journal of Cellular Physiology CrossRef
  26. Dimerization of the 4Ig isoform of B7-H3 in tumor cells mediates enhanced proliferation and tumorigenic signaling
    Margie N. Sutton et al, 2024, Communications Biology CrossRef
  27. Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology
    Gabriele J. Kembuan et al, 2024, Trends in Cancer CrossRef
  28. Soluble B7-H3 in Ovarian Cancer and Its Predictive Value
    O. V. Kovaleva et al, 2021, Bulletin of Experimental Biology and Medicine CrossRef